CORDIS EXOSEAL VASCULAR CLOSURE DEVICE

Device, Hemostasis, Vascular

FDA Premarket Approval P100013

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the exoseal vascular closure device. This device is indicated as follows: the exoseal vascular closure device (vcd) is indicated for femoral artery puncture site closure, reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional catheterization procedures using a standard 5f, 6f, or 7f vascular sheath introducer with up to 12 cm working length. Additionally, the exoseal vcd is indicated to reduce times to hemostasis and ambulation in patients who have undergone interventional catheterization procedures, using a standard 6f vascular sheath introducer up to a 12 cm working length, who have received preprocedural and/or intraprocedural glycoprotein (gp) iib/iiia inhibitor therapy.

DeviceCORDIS EXOSEAL VASCULAR CLOSURE DEVICE
Classification NameDevice, Hemostasis, Vascular
Generic NameDevice, Hemostasis, Vascular
ApplicantCordis Corporation
Date Received2010-04-01
Decision Date2011-05-19
Notice Date2011-06-03
PMAP100013
SupplementS
Product CodeMGB
Docket Number11M-0430
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address Cordis Corporation 1820 Mccarthy Boulevard milpitas, CA 95035
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P100013Original Filing
S026 2022-10-21 30-day Notice
S025
S024 2022-01-31 30-day Notice
S023 2021-11-17 30-day Notice
S022 2021-10-27 30-day Notice
S021 2021-09-10 30-day Notice
S020 2019-05-24 30-day Notice
S019 2019-04-05 30-day Notice
S018 2019-02-28 30-day Notice
S017 2018-07-12 30-day Notice
S016
S015 2017-08-11 Normal 180 Day Track No User Fee
S014 2017-04-11 135 Review Track For 30-day Notice
S013 2016-06-02 30-day Notice
S012 2015-07-23 30-day Notice
S011
S010 2014-03-24 30-day Notice
S009 2013-04-09 30-day Notice
S008 2012-12-03 30-day Notice
S007 2012-11-13 30-day Notice
S006 2012-09-13 30-day Notice
S005 2012-07-16 30-day Notice
S004 2012-06-19 30-day Notice
S003 2011-12-12 Real-time Process
S002 2011-08-30 30-day Notice
S001 2011-07-28 30-day Notice

NIH GUDID Devices

Device IDPMASupp
20705032058893 P100013 010
20705032058879 P100013 010
20705032058855 P100013 010

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.